Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -706.55% is 24% above its 5-year average of -924.94%, near the high end of its 5-year range (-260800712.77%–-48.19%).
44.19% above its 12-month average of -1266.09%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -772.60%.
EBITDA MARGIN
-706.55%
EBITDA MARGIN AVG TTM
-1266.09%
EBITDA MARGIN AVG 3Y
-1182.69%
EBITDA MARGIN AVG 5Y
-924.94%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+44.19%
CURRENT VS 3Y AVG
+40.26%
CURRENT VS 5Y AVG
+23.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
OneMedNet Corporation
Market Cap
$28.82M
EBITDA Margin
-706.55%
TTM Avg
-1266.09%
3Y Avg
-1182.69%
5Y Avg
-924.94%
Market Cap
$27.86M
EBITDA Margin
-40038.95%
TTM Avg
-34141.60%
3Y Avg
-20873.74%
5Y Avg
-16727.01%
Market Cap
$29.24M
EBITDA Margin
-17954.61%
TTM Avg
-17954.61%
3Y Avg
-17954.61%
5Y Avg
-17954.61%
Market Cap
$29.48M
EBITDA Margin
-2299.40%
TTM Avg
-2138.43%
3Y Avg
-3018.63%
5Y Avg
-2749.35%
Market Cap
$29.88M
EBITDA Margin
-2671.72%
TTM Avg
-3785.12%
3Y Avg
-14400.08%
5Y Avg
-14400.08%
Market Cap
$27.60M
EBITDA Margin
-11386.31%
TTM Avg
-11386.31%
3Y Avg
-11386.31%
5Y Avg
-3888.42%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OneMedNet Corporation (ONMD) | $28.82M | -706.55% | -1266.09% | -1182.69% | -924.94% |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.94M | N/A | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.86M | -40038.95% | -34141.60% | -20873.74% | -16727.01% |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | -2299.40% | -2138.43% | -3018.63% | -2749.35% |
| Context Therapeutics Inc. (CNTX)vs › | $30.07M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.15M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $29.88M | -2671.72% | -3785.12% | -14400.08% | -14400.08% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.60M | -11386.31% | -11386.31% | -11386.31% | -3888.42% |
| CervoMed Inc. (CRVO)vs › | $30.46M | -10097.04% | -6618.17% | -8743.58% | -8072.84% |
Gross Margin
-37.0%
EBITDA Margin
-706.5%
Operating Margin
-711.3%
Net Margin
-584.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -772.60% |
| 2026-03-31 | -2646.88% |
| 2025-12-31 | -344.89% |
| 2025-09-30 | -1257.06% |
| 2025-06-30 | -1309.03% |
| 2025-03-31 | -1614.60% |
| 2024-12-31 | -10153.85% |
| 2024-09-30 | -1673.94% |
| 2024-06-30 | -1076.65% |
| 2024-03-31 | -842.74% |
| 2023-12-31 | -1160.55% |
| 2023-09-30 | -589.26% |
| 2023-06-30 | -904.05% |
| 2023-03-31 | -731.50% |
| 2022-12-31 | -366.77% |
| 2022-06-30 | -281.94% |
| 2022-03-31 | -260800712.77% |
| 2021-12-31 | -103.36% |
| 2021-09-30 | -48.19% |
